Journal of Endocrinology (2005) 185, 577-592
DOI: 10.1677/joe.1.05770
© 2005 Society for Endocrinology
Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells
Liat Abovich Gilad,
Tali Bresler,
Julia Gnainsky,
Patricia Smirnoff and
Betty Schwartz
Institute of Biochemistry, Food Science and Nutrition, Faculty of Agricultural, Food and Environmental Quality Sciences, The Hebrew University of Jerusalem, P.O. Box 12, Rehovot 76100, Israel
(Requests for offprints should be addressed to B Schwartz; Email: bschwart{at}agri.huji.ac.il)
We previously demonstrated that 17ß-estradiol (E2) regulates the transcription and expression of the vitamin D receptor (VDR) in rat colonocytes and duodenocytes in vivo. The aim of the present study was to assess whether the extracellular signal-regulated kinase (ERK) induced by E2 is involved in regulating VDR expression. We compared E2-associated signaling activity in HT29 colon cancer cells, a non-classical E2-target, with that in MCF-7 breast cancer cells, the natural targets of the hormone. E2 did not affect proliferation of HT29 cells, but enhanced proliferation of MCF-7 cells. Vitamin D inhibited proliferation of both cell lines and the combined treatment induced potentiation of vitamin D activity. E2 upregulated VDR transcription and protein expression concomitantly with ERK 1/2 phosphorylation in both cell lines. PD98059, a specific mitogen-activated protein kinase (MAPK) inhibitor, prevented E2-mediated activation of ERK 1/2, with concomitant inhibition of VDR expression. ICI182780 inhibited VDR expression in HT29 and MCF-7 cell lines. A conjugate of E2 and bovine serum albumin upregulated phosphorylation of ERK 1/2 and concomitantly enhanced VDR expression in a similar fashion as the nonconjugated hormone. Expression of ER
and ERß was detected in MCF-7 and HT29 cell lines respectively, which localized to the nuclei, cytosol and caveolar membrane rather than non-caveolar membrane. Disruption of lipid rafts/caveolae by depleting cellular cholesterol with the cholesterol-binding reagent ß-methylcyclodextrin blocked ERK 1/2 phosphorylation concomitantly with VDR upregulation. The tyrosine phosphorylation inhibitor suramin and src kinase inhibitor PP2 inhibited both ERK 1/2 phosphorylation and VDR expression. E2 induced phosphorylation of Raf and Jun in a time-dependent manner. The Ras/Raf dependent inhibitor of transactivation sulindac sulfide also blocked E2 effects. The specific c-Jun phosphorylation inhibitor SP600125 dose dependently inhibited c-Jun phosphorylation and VDR expression. The MAPK/ERK kinase inhibitor PD 98059 downregulated both c-Jun phosphorylation and VDR expression indicating that upstream and downstream events in the signaling cascade are all related to the control of VDR expression. Taken together, our data suggest that E2 binds to receptors compartmentalized to membranal caveolar domains in HT29 and MCF-7 cells, inducing ERK 1/2 activation and transcriptional activity, which finally results in upregulation of expression of the VDR gene.
This article has been cited by other articles:
|
|
|
|
 
C. C. Weige, K. F. Allred, and C. D. Allred
Estradiol Alters Cell Growth in Nonmalignant Colonocytes and Reduces the Formation of Preneoplastic Lesions in the Colon
Cancer Res.,
December 1, 2009;
69(23):
9118 - 9124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. S. Migalovich, V. Kalchenko, N. Nevo, G. Meir, F. Kohen, and M. Neeman
Harnessing Competing Endocytic Pathways for Overcoming the Tumor-Blood Barrier: Magnetic Resonance Imaging and Near-Infrared Imaging of Bifunctional Contrast Media
Cancer Res.,
July 1, 2009;
69(13):
5610 - 5617.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Dominguez, E. Hu, M. Zhou, and M. Baudry
17{beta}-Estradiol-Mediated Neuroprotection and ERK Activation Require a Pertussis Toxin-Sensitive Mechanism Involving GRK2 and {beta}-Arrestin-1
J. Neurosci.,
April 1, 2009;
29(13):
4228 - 4238.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. T. Todorov, M. Desch, T. Schubert, and A. Kurtz
The Pal3 Promoter Sequence Is Critical for the Regulation of Human Renin Gene Transcription by Peroxisome Proliferator-Activated Receptor-{gamma}
Endocrinology,
September 1, 2008;
149(9):
4647 - 4657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Gilad and B. Schwartz
Association of estrogen receptor {beta} with plasma-membrane caveola components: implication in control of vitamin D receptor
J. Mol. Endocrinol.,
June 1, 2007;
38(6):
603 - 618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-Y. Park, S. P. Murphy, L. R. Wilkens, A. M. Y. Nomura, B. E. Henderson, and L. N. Kolonel
Calcium and Vitamin D Intake and Risk of Colorectal Cancer: The Multiethnic Cohort Study
Am. J. Epidemiol.,
April 1, 2007;
165(7):
784 - 793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q.-P. Li, X. Qi, R. Pramanik, N. M. Pohl, M. Loesch, and G. Chen
Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity
J. Biol. Chem.,
January 19, 2007;
282(3):
1544 - 1551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Gilad, O. Tirosh, and B. Schwartz
Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells.
J. Endocrinol.,
November 1, 2006;
191(2):
387 - 398.
[Abstract]
[Full Text]
[PDF]
|
|
|
Copyright © 2005 by the Society for Endocrinology.
